Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Paying user area
Try for free
Merck & Co. Inc. pages available for free this week:
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Analysis of Solvency Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Debt to Equity since 2005
- Total Asset Turnover since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Merck & Co. Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Merck & Co. Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
The overall capital structure exhibits a fluctuating trend in leverage over the analyzed period. Total liabilities decreased from an initial high of 70.24% in March 2021 to a low of 56.49% by March 2023, before trending upward again to reach 64.31% by March 31, 2026. Consequently, total equity followed an inverse trajectory, peaking at 43.51% in March 2023 and declining to 35.69% by the end of the period.
- Long-Term Debt Obligations
- A significant increase in long-term debt, excluding the current portion, is observed toward the end of the timeline. After remaining relatively stable between 24% and 30% for several years, this component rose to 36.27% by March 31, 2026, indicating a strategic shift toward increased long-term borrowing to finance operations or acquisitions.
- Current Liability Composition
- Current liabilities remained relatively stable, generally oscillating between 20% and 25% of total liabilities and equity. Accrued and other current liabilities constitute the largest portion of this category, consistently ranging between 10% and 15%. Income taxes payable showed a modest increase in the latter half of the period, rising from approximately 1.4% in 2022 to a peak of 4.50% in March 2024.
- Equity and Shareholder Value
- Retained earnings remained a primary driver of equity, though they experienced volatility, fluctuating between 50.52% and 58.27%. A substantial negative balance in treasury stock is maintained throughout the period, ranging from -46.03% to -62.50%, which suggests a consistent and aggressive share repurchase program. Other paid-in capital showed a gradual downward trend, decreasing from 48.56% in June 2021 to 35.11% by March 2026.
- Noncurrent Liability Trends
- Other noncurrent liabilities experienced a steady decline, falling from 13.47% in March 2021 to 5.94% by March 2026. This reduction offset some of the growth in long-term debt, although the overall trajectory of noncurrent liabilities turned upward in the final quarters, reaching 43.37% by March 31, 2026.